December 18, 2025 lands like a low rumble you feel before you hear it. Edison Scientific just closed a $70M seed round at a $250M post-money valuation, and this is not another AI headline built on vibes and demo-day lighting. This one smells like lab solvent, peer review, and nights that run long because the data refuses to behave. Spark Capital and Triatomic Capital came in as co-leads alongside a U.S.-based biotech investor who clearly understands that discovery, not compute, is the real choke point. Jeff Dean and Dmitri Alperovitch showing up as participants is not name-dropping, it is pattern recognition.
Edison Scientific did not crawl out of a garage or stumble out of an accelerator. It walked out of FutureHouse, the nonprofit research lab founded in Sept 2023, after the May 2025 platform launch triggered inbound interest from VP and C-suite leaders at 6 of the top 10 pharma companies. When that kind of demand shows up early, you either slow it down with committees or you build something real. Edison incorporated in Nov 2025 with Samuel G. Rodriques as CEO and Andrew White as CTO, two builders who have spent years earning the right to move with conviction.
The product is Kosmos, an AI scientist that does not chit-chat or improvise. It executes. A single run processes roughly 1,500 scientific papers, generates more than 42,000 lines of analysis code, and coordinates around 200 agent rollouts over sessions lasting up to 12 hours. Everything is traceable, auditable, and reproducible. Across 7 discoveries spanning neuroscience, genetics, aging, and materials science, Kosmos demonstrated a 79–80% reproducibility rate. Three runs independently reproduced unpublished human research without access to the originals. Four more generated novel findings now moving through wet-lab validation. That is not acceleration theater. That is time compression with receipts.
Samuel G. Rodriques brings a physicist’s allergy to hand-waving, shaped at MIT, Cambridge, and the Francis Crick Institute, capped with a TIME100 AI nod in 2025. Andrew White brings the chemical engineering and ML firepower behind ChemCrow, ether0, and PaperQA, systems many scientists already rely on quietly and daily. Around them is a 30-person team spanning SpaceX propulsion, FDA regulatory systems at Palantir, pandemic-scale genomics, and platform engineering designed for pressure, not pitch decks.
The $70M will scale infrastructure, expand the team, and push Kosmos deeper into pharma, biotech, and advanced academic research. Pricing is blunt at $200 per run, with free academic access because discovery should not belong only to those with procurement departments. Edison Scientific is not selling conversation. It is selling months of thinking, condensed into a day, citations attached, excuses removed.
Startups Startup Funding Venture Capital Seed Round AI Automation AI Agents Biotech Research Scientific Research Data Data Driven Infrastructure Technology Innovation Tech Ecosystem Startup Ecosystem Hiring Tech Hiring DCTalks
